Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Córdoba
Clinical trial register · Spain

Clinical Trials in Córdoba, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Madrid 78 Barcelona 58 Valencia 39 Seville 29 Majadahonda 22
Narrow the registerReset
Recruitment status
Phase
Site location
Madrid78 Barcelona58 Valencia39 Seville29 Majadahonda22
All 68 locations
Target enrolment
to

Trials with a site in Córdoba

16 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
AbbVie
Phase 3
561
Córdoba, Donostia / San Sebastian, Majadahonda, Asturias, Seville, Barcelona, Madrid, Valencia
2025-11-05
Recruiting
AbbVie
Phase 2
180
Sabadell, Seville, Bilbao, A Coruña, Córdoba, Madrid, Valencia
2025-06-20
Recruiting
AbbVie
Observational
700
A Coruña, Badalona, Sabadell, Córdoba, Marbella, Pamplona, Seville, Manises
2025-03-28
Active, closed
AbbVie
Observational
1,200
Sant Joan Despí, Jerez de la Frontera, Córdoba, Las Palmas de Gran Canaria, Leganés, Oviedo, Galdakao, Barcelona
2024-02-19
Recruiting
AbbVie
Phase 3
1,500
L'Hospitalet de Llobregat, Fuenlabrada, Barcelona, Córdoba, Madrid, Valencia
2023-10-11
Active, closed
AbbVie
Phase 2
130
Santander, Córdoba, Majadahonda, Pamplona, Barcelona, Madrid, Seville, Zaragoza
2023-09-21
Active, closed
AbbVie
Phase 3
520
A Coruña, L'Hospitalet de Llobregat, Córdoba, Málaga, Pamplona, Barcelona, Girona, Madrid
2023-03-15
Active, closed
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
AbbVie
Phase 1
256
Badalona, Córdoba, Barcelona, Madrid, Valencia
2023-01-11
Active, closed
AbbVie
Phase 2
125
A Coruña, Badalona, Córdoba, Pamplona, Badajoz, Barcelona, Lleida, Madrid
2022-09-28
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
AbbVie
Phase 3
735
Santiago de Compostela, L'Hospitalet de Llobregat, Córdoba, Las Palmas de Gran Canaria, Majadahonda, Barcelona, Madrid
2022-01-13
Active, closed
AbbVie
Phase 3
531
Badalona, Córdoba, Pozuelo de Alarcón, Barcelona, Madrid, Salamanca, Seville, Valencia
2020-09-10
Active, closed
AbbVie
Phase 3
1,242
Ferrol, Sabadell, Majadahonda, Vigo, Gijón, Barcelona, Córdoba, Madrid
2018-08-28
Active, closed
AbbVie
Phase 3
950
A Coruña, Santiago de Compostela, Santander, Las Palmas de Gran Canaria, Barcelona, Córdoba, Madrid, Salamanca
2017-01-31
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/c-rdoba

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Córdoba that also match the filters currently applied.

How many clinical trials are recruiting in Córdoba?

5 of the 16 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Córdoba), 16 studies
PhaseStudiesRecruitingShare
Phase 39356.3%
Phase 23118.8%
Observational2112.5%
Phase 1106.3%
Phase 2/3106.3%

Most active sponsors

Lead sponsors with the most studies (Córdoba)
Lead sponsorStudiesRecruiting
AbbVie165
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.